High-throughput screening (HTS) is a large-scale hierarchical process in which a large number of chemicals are tested in multiple stages. Conventional statistical analyses of HTS studies often suffer from high testing error rates and soaring costs in large-scale settings. This article develops new methodologies for false discovery rate control and optimal design in HTS studies. We propose a two-stage procedure that determines the optimal numbers of replicates at different screening stages while simultaneously controlling the false discovery rate in the confirmatory stage subject to a constraint on the total budget. The merits of the proposed methods are illustrated using both simulated and real data. We show that the proposed screening procedure effectively controls the error rate and the design leads to improved detection power. This is achieved at the expense of a limited budget.
In both pharmaceutical industries and academic institutions, high throughput screening (HTS) is a primary approach for selection of biologically active agents or drug candidates from a large number of compound [1] . Over the last 20 years, HTS has played a crucial role in fast-advancing fields such as screening of small molecule or short interference RNA (siRNA) screening in stem cell biology [2] or molecular biology ( [3] [4]), respectively. HTS is a large-scale and multi-stage process in which the number of investigated compounds can vary from hundreds to millions. The stages involved are target identification, assay development, primary screening, confirmatory screening, and follow-up of hits [5] .
The accurate selection of useful compounds is an important issue at each aforementioned stage of HTS. In this article we focus on statistical methods at the primary and confirmatory screening stages. A library of compounds is first tested at the primary screening stage, generating an initial list of selected positive compounds, or 'hits'. The hits are further investigated at the confirmatory stage, generating a list of 'confirmed hits'. In contrast to the assays used at the primary screening stage, the assays for the confirmatory screening stage are more accurate but more costly.
Conventional statistical methods, such as the z-score, robust z-score, quartile-based, and strictly standardized mean difference methods have been used for selection of compounds as hits or confirmed hits ([1] [5] ). However, these methods are highly inefficient due to three major issues. First, these methods ignore the multiple comparison problem. When a large number of compounds are tested simultaneously, the inflation of type I errors or false positives becomes a serious issue and may lead to large financial losses in the follow-up stages. The control of type I errors is especially crucial at the confirmatory screening stage due to the higher costs in the hits follow-up stage. The family-wise error rate (FWER), the probability of making at least one type I error, is often used to control the multiplicity of errors ( [6] [7] [8] [9] [10]). However, in large-scale HTS studies, the FWER criterion becomes excessively conservative, such that it fails to identify most useful compounds. In this study we consider a more cost-effective and powerful framework for large-scale inference; the goal is to control the false discovery rate (FDR) [11] , the expected proportion of false positive discoveries among all confirmed hits.
Second, the data collected in conventional HTS studies often have very low signal to noise ratios (SNR). For example, in most HTS analyses, only one measurement is obtained for each compound at the primary screening stage [1] ; existing analytical strategies often lead to a high false negative rate, an overall inefficient design, and hence inevitable financial losses (since missed findings will not be pursued).
Finally, in the current HTS designs, an optimal budget allocation between the primary screening and confirmatory screening stages is not considered. Ideally the budgets should be allocated efficiently and dynamically to maximize the statistical power. Together, the overwhelming number of targets in modern HTS studies and the lack of powerful analytical tools have contributed to high decision error rates, soaring costs in clinical testing and declining drug approval rates [12] . This article proposes a new approach for the design and analysis of HTS experiments to address the aforementioned issues. We first formulate the HTS design problem as a constrained optimization problem where the goal is to maximize the expected number of true discoveries subject to the constraints on the FDR and study budget. We then develop a simulation-based computational procedure that dynamically allocates the study budgets between the two stages and effectively controls the FDR in the confirmatory stage.
Simulation studies are conducted to show that, within the same study budget, the proposed method controls the FDR effectively and identifies more useful compounds compared to conventional methods. Finally, we confirm the usefulness of our methods employing the data obtained from a chemical screening.
Powerful strategies and methodologies have been developed for the design and analysis of multistage experiments. However, these existing methods cannot be directly applied to the analysis of HTS data. Satagopan et al. [13] proposed a two-stage design for genome-wide association studies; compared to conventional single-stage designs, their two-stage design substantially reduces the study cost, while maintaining statistical power. However, the error control issue and optimal budget allocation between the stages were not considered.
Posch et al. [14] developed an optimized multistage design for both FDR and FWER control in the context of genetic studies. The above methods are not suitable for HTS studies since the varied cost per compound at different stages were not taken into account.
Müller et al. [15] and Rossell and Müller [16] studied the optimal sample size problem and developed a two-stage simulation based design in a decision theoretical framework with various utility functions. However, it is unclear how the sample size problem and budget constraints can be integrated into a single design. In addition, the varied stage-wise costs were not considered in their studies. Other related works on multiple comparison issue in multistage testing problems include Dmitrienko et al. [17] and Goeman and Mansmann [18] . The results cannot be applied to our problem due to similar aforementioned issues.
Compared to existing methods, our data-driven procedure simultaneously addresses the error rate control, varied measurement costs across stages and optimal budget allocation, and is in particular suitable for HTS studies.
The remainder of the article is organized as follows. Section 2 presents the model, problem formulation, and proposed methodology. Numerical results are given in Section 3, where we first compare the proposed method with the conventional methods using simulations, and then illustrate the method using HTS data. Section 4 concludes the article with a discussion of results and future work. Technical details of the computation are provided in Appendix A.
Model, Problem Formulation, and Methods
We first introduce a multi-stage two-component random mixture model for HTS data (Section 2.1), and then formulate the question of interest as a constrained optimization problem (Section 2.2). Finally, we develop a simulation-based computational algorithm for optimal design and error control in HTS studies (Sections 2.3 and 2.4).
A random effect multi-stage normal mixture model
We start with a popular random mixture model for single-stage studies and then discuss how it may be generalized to describe HTS data collected over multiple stages. All m compounds in the HTS library can be divided into two groups: null cases (noises) and nonnull cases (useful compounds). Let p be the proportion of non-nulls and θ i be a Bernoulli(p) variable, which takes the value of 0 for a null case and 1 for a non-null case. In a twocomponent random mixture model, the observed measurements x i are assumed to follow the conditional distribution
for i = 1, · · · , m, where f 0 and f 1 are the null and non-null density functions respectively.
Marginally, we have
The marginal density f is also referred to as the mixture density. is the number of compounds tested at stage I. According to (2.1), we assume the following random mixture model:
where f 10 and f 11 are assumed to be the stage I density functions for the null and non-null cases respectively. We shall first focus on a normal mixture model and take both f 10 and f 11 as normal density functions. Extensions to more general situations are considered in the discussion section.
First consider the situation where there is only one replicate per compound. Marginally the means of both the null and non-null densities are assumed to be zero. The assumption of zero mean can be more generalized with more technicalities. Here a zero mean can indicate that the non-null can be either a higher or a lower valued observation. Initial transformation of the data may be needed to justify this.
We consider a hierarchical model. Let the measurement 'noise' distribution follow Suppose that m 2 compounds are selected from stage I to enter stage II. The observed measurements, denoted as x 2 = (x 21 , · · · , x 2m 2 ), are assumed to follow another random mixture model:
Here f 20 and f 21 are the null and non-null density functions respectively, and we assume normality for both densities. Consider the situation with one replicate per hit. Here again, marginally, the mean of both the null and non-null densities are assumed to be zero. Let 
Problem formulation
We aim to find the most efficient HTS design that identifies the largest number of true confirmed hits subject to the constraints on both the FDR and available funding. Our design provides practical guidelines on the choice of the optimal number of replicates at stage I, the selection of the optimal number of hits from stage I, and the optimal number of replicates at stage II accordingly, determined by study budget.
This section formulates a constrained optimization framework for the two-stage HTS analysis. We start by introducing some notation. Let B denote the total available budget. The relations of variables above can be described by the following equations:
where,
and
The optimal design involves determining the optimal combination of r 1 and |A 1 | to maximize the expected number of confirmed hits subject to the constraints on the total budget and the FDR at stage II.
It is important to note that the two-stage study can be essentially viewed as a screenand-clean design, and we only aim to clean the false discoveries at stage II due to the high cost at the subsequent hits follow-up stage. The main purpose of stage I is to reduce the number of compounds to be investigated in the next stage to save study budget; the control of false positive errors is not a major concern at stage I.
In the next two subsections, we first review the methodology on FDR control and then develop a data-driven procedure for analysis of two-stage HTS experiments.
FDR controlling methodology in a single-stage random mixture model
Due to the high cost of hits follow-up, we propose to control the FDR at the confirmatory screening stage (stage II). The FDR is defined as the expected proportion of false positive discoveries among all rejections, where the proportion is zero if no rejection is made. In HTS studies, the number of compounds to be screened can vary from hundreds to millions and conventional methods for controlling the FWER are overly conservative. Controlling the FDR provides a more cost-effective framework in large-scale testing problems and has been widely used in various scientific areas such as bioinformatics, proteomics, and neuroimaging.
Next we briefly describe the z-value adaptive procedure proposed in Sun and Cai [19] .
In contrast to the popular FDR procedures that are based on p-values, the method is based on thresholding the local false discovery rate (Lfdr) [20] . The Lfdr is defined as Lfdr(x) := P (null|x is observed), the posterior probability that a hypothesis is null given the observed data. In a compound decision theoretical framework, it was shown by Sun and Cai [19] that the Lfdr procedure outperforms p-value based FDR procedures. The main advantage of the method is that it efficiently pools information from different samples. The Lfdr procedure is in particular suitable for our analysis because it can be easily implemented in the two-stage computational framework that we have developed. As we shall see, the Lfdr statistics (or the posterior probabilities) can be computed directly using the samples generated from our computational algorithms.
Consider a random mixture model (2.1). The Lfdr can also be computed as
where x i is the observed data associated with compound i, and
is the marginal density function. The Lfdr procedure operates in two steps: ranking and thresholding. In the first step, we order the Lfdr values from the most significant to the least significant:
, the corresponding hypotheses are denoted by
In the second step, we use the following step-up procedure to determine the optimal threshold: Let
Then reject all H (i) , i = 1, · · · , k. This procedure will be implemented in our design to control the FDR at stage II. When the distributional informations (for e.g., the non-null proportion p and the null and non-null densities) are unknown, we need to estimate it from the data. Related estimation issues, as well as the proposed two-stage computational algorithms, are discussed in the next subsection.
Data-driven computational algorithm
This section proposes a simulation-based computational algorithm that controls the FDR and dynamically allocates the study budgets between the two stages. The main ideas are described as follows. For each combination of specific values of r 1 and |A 1 |, we apply the Lfdr procedure and estimate E|A 2 |, the expected size of A 2 (recall that A 2 is the subset of final confirmed hits). The optimal design then corresponds to the combination of r 1 and |A 1 | that yields the largest expected size of confirmed hits, subject to the constraints on the FDR and study budget. A detailed description of our computational algorithm for a two-point normal mixture model is provided in Appendix A.2. The model will be used in both our simulation studies and real data analysis.
The key steps in our algorithms include (i) estimating the Lfdr statistics, and (ii) computing the expected sizes of confirmed hits via simulations. The algorithm can be extended to a k-point normal mixture without essential difficulty by, for example, implementing the estimation methods described by Komárek [21] .
Suppose that, prior to stage I we have obtained information about the unknown parameters σ 10 , σ 11 , and p 1 from some pilot studies. If not, we must obtain at least one replicate of x 1 = (x 11 , · · · , x 1m 1 ) to proceed. Then by using the MC (Monte Carlo) based algorithm described in the Appendix A.1, we can estimate the unknown parameters σ 10 , σ 11 , and p 1 . Next we simulate measurements for a given value of r 1 according to model (2.2). We then select |A 1 | most significant compounds to proceed to stage II. Different combinations of r 1 and |A 1 | will be considered to optimize the design. At stage II, we again have two situations of which the ideal case is that we have some prior knowledge about the values of σ 20 and σ 21 from some pilot studies. Otherwise we need to obtain some preliminary data
2 ) with at least one replicate. Using MC algorithm, we can estimate the unknown parameters σ 20 and σ 21 . Following (2.3) and information on θ 1i from stage I, we simulate measurements for a specific value of r 2 calculated by the relations (2.4)-(2.6).
Applying the Lfdr procedure (2.7) at the nominal FDR level, we can determine the subset of confirmed hits A 2 .
For each combination of r 1 and |A 1 |, the algorithm will be repeated N times (in our numerical studies and data analysis we use N = 100); the expected size of confirmed hits can be calculated as the average sizes of these subsets. Therefore we can obtain the expected sizes of confirmed hits for all combinations of r 1 and |A 1 |. Finally the optimal design is determined as the combination of r 1 and |A 1 | that yields the largest expected size of confirmed hits.
The operation of our computational algorithm implies that the FDR constraint will be fulfilled and the detection power will be maximized.
Numerical Results
We now turn to the numerical performance of our proposed method via simulation studies and a real data application. In the simulation studies, we compare the FDR and the number of identified true positive compounds of the proposed procedure with replicated one-stage and two-stages Benjamini-Hochberg (BH) procedures. The methods are compared for efficiency at the same study budget. To investigate the numerical properties of the proposed method in different scenarios, we consider two simulation settings, discussed in Section 3.1.
The real data application is discussed in Section 3.2. The two-component random mixture model (2.1) is used to simulate data for both stages, which were used as the preliminary data. We then followed the procedure described in Section 2.4 with N = 100. For the conventional methods, we followed the approaches is proposed method, is two-stages BH, and is one-stage BH. All methods have a budget of about $250,000.
Simulation studies

Simulation study 2
In this simulation, we used only a single value of p 1 = 0.1 to simulate the data. The FDR level is varied over a range of values from 0.02-0.3. Other simulation parameters are the same as that in simulation study 1. The results are summarized in Figure 2 . The following additional observations can be made. The proposed and two-stages BH tries to adapt to the increasing FDR level, indicated by the slope close to 1 in the plot (a). From plot (b) we observe that the gain in power is higher when the desired level of FDR is lower. This can be explained by higher number of rejections (or higher number of confirmed hits) while maintaining the FDR, which is a ratio. This neatly ties to the fact that our proposed procedure exploits the number of confirmed hits as the objective value to maximize. 
Application to a small molecule HTS study
We analyze the study in Mckoy et al. [22] . The goal of the study is to identify new inhibitors of the amyloid beta peptide, the accumulation of which is considered to be a major reason for Alzheimer's disease. This dataset has also been analyzed in Cai and Sun [23] . The compound library consists of 51840 compounds. The dataset consists of three sets of standardized z-scores. The three replications of the z-scores are summarized in a histogram in Figure 3 .
We apply the Monte Carlo method explained in Appendix A.1 to estimate the parameters. Before applying the parameter estimation we first de-mean the z-scores. All the estimates of the parameters including the value of the mean is summarized in Table 1 . We note that the estimates for the z-scores B and C are close to that obtained in Cai and Sun [23] . The estimate of the non-null proportion for z-score A is higher than the others. This may be explained by the heavier left-tail as observed in the histogram. For the rest of our analyses, we choose to work with the parameter estimates obtained from z-scores B. The information on costs for the stages I and II screening is not available for this study.
For illustration purpose, we assume that the total budget for the study is B = $500, 000. The results from the proposed algorithm are summarized in Table 2 . For a fixed precision it is observed that the number of hits identified at stage I decreases with increase in cost of stage II. This is not counterintuitive as it allows for more replications at stage II due to the fixed budget constraint. Moreover we observe that, the overall expected power, again at the optimal selection, decreases. This may be explained by the fact that the procedure automatically adjusts to control the false discovery rate at the desired level, which results in the procedure having lower power for more expensive stage II experiments, everything else being fixed. What is further interesting to note is, the number of optimal replications in stage I does not change very much with change in cost of stage II. One explanation could be that: a reasonable number of replications is essential to maintain the proportion of true compounds identified at stage I. 
Discussion
In this article we developed a two-stage computational procedure for optimal design and error control for HTS studies. By utilizing the Monte Carlo based simulation techniques, our data-driven design calculates the optimal replicates at each stage. The new design promises to significantly increase the signal to noise ratio in HTS data. This would effectively reduce the number of false negative findings and help identify useful compounds for drug development in a more cost-effective way. By controlling the FDR at the confirmatory screening stage, the false positive findings and hence the financial burdens on the hits follow-up stage can be effectively controlled. Finally, under our computational framework, the funding has been utilized efficiently with an optimized design, which allocates available budgets dynamically according to the estimated signal strengths and expected number of true discoveries.
We have assumed a two-point normal mixture model. Although this is a reasonable assumption in some applications, it is desirable to extend the theory and methodology to handle situations where the data follow skewed normal, or skewed t distributions (see, for example, Frühwirth-Schnatter and Pyne [24] ). In addition, the two-point mixture model
can be extended to a k-point normal mixture model where k may be unknown. The problem for estimating k and the mixture densities has been considered, for example, by Richardson and Green [25] .
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A Appendix
Here we provide more details for the estimation of the model parameters and implementation of the proposed algorithm.
A.1 Monte Carlo estimates of parameters
For the two-component random mixture model,
. Then note that marginally,
where
We choose to assume the mean to be zero for the signals, that is,
If not, the data has to be appropriately transformed.
Bayesian formulation is used to estimate the parameters (p, σ where we choose α = 5.58 which may be varied. Note that there are other ways of choosing priors for the parameters (for e.g., choosing inverse gamma for the variance, and beta prior for the the non-null proportion). As discussed in Scott and Berger [26] there is no one "right" way to do this and can be viewed as a practitioner's discretion. We have provided one formulation that computes estimate of the parameters using preliminary data.
Maximum likelihood estimation, computed by expectation-minimization (EM) algorithm, may also be used in this set-up.
To compute the posterior expectations of σ These integrals are computed using Monte Carlo based importance sampling method. We follow the method presented in Scott and Berger [26] . Section 3 of the reference provides more details. The choice of a in their method is again at user's discretion. Here we choose a = 5. Our simulation results confirm the successful estimation of the model parameters.
A.2 Implementation of the proposed procedure Find the number of confirmed hits after stage II using (2.7) in each observation;
Average over the 100 observations to compute expected hits.
if expected hits > optimal expected hits then Set optimal expected hits = expected hits;
Note the optimal values of r 1 and |A 1 |;
Increase values of r 1 and |A 1 |.
else Increase values of r 1 and |A 1 |.
end end Algorithm 1: is proposed to determine the optimal values of r 1 and |A 1 |. The value of r 2 is then determined by the study budget.
